Living In Parallel Reality

Published date07 April 2022
Subject MatterIntellectual Property, Patent
Law FirmGorodissky & Partners
AuthorMr Vladimir Biriulin

We are living in turbulent days. Almost every day one may witness interpretation by IP practitioners of several decrees issued by the Russian government. The decrees are:

  • No 3718-p of Dec.31,2020. The government allowed the use of several patents for one year without permission of the patent owners because of dramatic situation with Covid-19.
  • No 3915-p of Dec.28,2021. The government extended permission for one more year because of continued pandemic.
  • No 1767 of Oct.18,2021 The government ordered compensation for the use of the above patents - 0.5% of the proceeds of the Russian producer of the drug.
  • No 299 of March 06,2021 The government ordered "0" compensation for the use of the above patents because the owners are residents of an "unfriendly country".

As may be seen, all decrees center around a drug for the treatment of Covid-19. Nothing else is implied.

This last decree triggered a raft of articles in the media. Surprisingly, almost all article generalize the extent of the decree. Just several examples:

  • The Russian government has decreed that owners of Russian patents from designated "unfriendly" countries will not be entitled to any compensation for use of their patents.
  • The Russian government has decreed that owners of Russian patents from "unfriendly" countries will not be entitled to any compensation for use of their patents.
  • Owners of Russian patents should not expect to be able to enforce their patent rights in Russia in the near term.

Some authors include trademarks in the scope of their analysis of the situation though trademarks are not mentioned in any of the decrees..

Such citations may be continued without end. It seems that the authors did not see the texts of those decrees or, if they did, they...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT